Nuvation Bio Inc (NUVB) Directors and Executive Officers

Officers & Directors

KIM BLICKENSTAFF
Director

DANIEL G. WELCH
Chair of the Board of Directors

W. ANTHONY VERNON
Director

David Hung, M.D.
President and Chief Executive Officer (Principal Executive Officer)

ROBERT MASHAL, M.D.
Director

MOSES MAKUNJE
VP, Finance (Principal Financial and Accounting Officer)

KATHRYN E. FALBERG
Director

ROBERT B. BAZEMORE, JR.
Director ,

Nuvation Bio Inc currently has 43 employees.

News about Nuvation Bio Inc Key Personnel

Nuvation Bio Appoints Colleen Sjogren as Chief Commercial Officer to Drive Growth Strategy amidst Financial Challenges

In an effort to strengthen its commercial capabilities and drive growth amid financial challenges, Nuvation Bio Inc (NYSE: NUVB), a biopharmaceutical company specializing in addressing unmet needs in oncology, has appointed Colleen Sjogren as its Chief Commercial Officer. The company unveiled the news today, emphasizing Sjogren s role in overseeing Nuvation Bio s commercial strategy and operations, including marketing, sales, and market access.
The appointment of Sjogren comes at a critical juncture for Nuvation Bio, as the company has reported a cumulative net loss of $-83 million during the twelve months ending in the third quarter of 2023. This has resulted in a negative return on assets (R...

Nuvation Bio Strengthens Leadership with Addition of Seasoned Biotech Veteran, Dr. Robert Mashal, to its Board of Directors

Nuvation Bio Boosts Board of Directors with Addition of Dr. Robert Mashal
Nuvation Bio Inc., a leading biopharmaceutical company focused on addressing significant unmet needs in oncology with innovative therapeutic candidates, has announced the appointment of Dr. Robert Mashal to its Board of Directors. This exciting development comes as the company strives to further advance its groundbreaking solutions for cancer treatment.
Dr. Mashal brings extensive expertise and experience to Nuvation Bio s Board of Directors, making him a valuable asset to the company. As a seasoned veteran in the biotech industry, his insights and strategic guidance will contribute to the company s success in developing novel ...